Publications

中



Home > publication > Publications

NBbiolab is a specialized company focused on the early discovery of single domain antibodies,

offering professional expertise and high-quality custom services to support partners in their drug discovery efforts.

Publication



2023
Nature Communications

Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1

Chen Wang, Leiye Yu, Jiying Zhang, Yanxia Zhou, Bo Sun, Qingjie Xiao, Minhua Zhang, Huayi Liu, Jinhong Li, Jialu Li, Yunzi Luo, Jie Xu, Zhong Lian, Jingwen Lin, Xiang Wang, Peng Zhang, Li Guo, Ruobing Ren & Dong Deng


2022
Nature Communications

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.

Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi …


2022
Molecular Pharmaceutics

99mTc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression

Linqing Shi, Bo Chen, Tianyu Liu, Liqiang Li , Biao Hu, Chenzhen Li, Bing Jia, Fan Wang


2022
EJNMMI

Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells

Yan Wang, Chao Wang, Minzhou Huang, Songbing Qin, Jun Zhao, Shibiao Sang, Meng Zheng, Yicong Bian, Chenrong Huang, Hua Zhang, Lingchuan Guo, Jiwei Jiang, Chun Xu, Na Dai, Yushuang Zheng, Jiajun Han, Min Yang, Tao Xu, Liyan Miao


2022
Frontiers in Immunology

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding

Jing Yang, Sheng Lin, Honglu Sun, Zimin Chen, Fanli Yang, Xi Lin, Liyan Guo, Lingling Wang, Ao Wen, Xindan Zhang, Yushan Dai, Bin He, Yu Cao, Haohao Dong, Xianbo Liu, Bo Chen, Jian Li, Qi Zhao, Guangwen Lu


2020
RSC Advances

Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum

Qi Chen, Danyang Sun, Hua Pei, Benchao Su, Kunlu Bao, Hongmei Cao, Chenghui Zhang, Bruce D Hammock, Xing Liu

Our customer service representatives are available 24 hours a day, 7 days a week.

INFORMATION

Tel：+86 4008677715

E-mail：service@nb-biolab.com

Address：SME Incubation Park, 319 Qingpi Avenue, Chengdu, China.

Working time：9:00-18:00

Linkedin Twitter Facebook

Publications

Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.

99mTc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression

Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding

Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum

PLATFORM

Services

INFORMATION